51. Low membrane protein sulfhydrils but not glucose-6-phosphate dehydrogenase deficiency predict ribavirin-induced hemolysis
- Author
-
I. Grattagliano, Stefan Russmann, V. O. Palmieri, Bernhard H. Lauterburg, G. Palasciano, F. Bihl, and P. Portincasa
- Subjects
Pharmacology ,Chemistry ,Thiobarbituric acid ,Ribavirin ,Erythrocyte fragility ,Glutathione ,medicine.disease ,medicine.disease_cause ,Hemolysis ,Dipyridamole ,chemistry.chemical_compound ,Biochemistry ,medicine ,Pharmacology (medical) ,Oxidative stress ,Glucose-6-phosphate dehydrogenase deficiency ,medicine.drug - Abstract
Purpose Hemolysis is a frequent adverse effect of ribavirin (RBV). Oxidative stress has been suggested to play a role, but mechanisms and predictive risk factors are unknown. Methods: Markers of redox status were determined in erythrocytes from hepatitis C infected patients with and without G6PD-deficiency before and during RBV treatment, and erythrocytes were incubated with RBV and dipyridamole, diethylmaleate or glutathione ester. Results: 5 out of 30 patients developed major RBV-induced hemolysis, which was associated with a more pronounced increase in thiobarbituric acid reactive substances (+22.5 vs. +9.4 nmol/gHb, p
- Published
- 2004
- Full Text
- View/download PDF